Core Insights - Nevada Sunrise Metals Corporation has entered into an investor relations agreement with Nicholas Winton to enhance investor awareness of its business activities [1][2] - The agreement, accepted by the TSX Venture Exchange, will last for 12 months at a cost of CAD$2,400 per month [2] - Nicholas Winton currently owns 80,000 shares of Nevada Sunrise [2] Company Overview - Nevada Sunrise is a junior mineral exploration company based in Vancouver, BC, focusing on gold, copper, and lithium projects in Nevada, USA [3] - The company holds the right to purchase a 100% interest in the Griffon Gold Mine Project, located approximately 50 kilometers southwest of Ely, NV [3] - Nevada Sunrise also has the right to earn a 100% interest in the Coronado Copper Project, located about 48 kilometers southeast of Winnemucca, NV [4] - The company owns 100% interests in the Gemini West, Jackson Wash, and Badlands lithium projects, all situated in the Lida Valley, Esmeralda County, NV [4] - Additionally, Nevada Sunrise possesses Nevada Water Right Permit 86863, located in the Lida Valley basin near Lida, NV [4]

Core Points - Aurania Resources Ltd. has successfully closed a non-brokered private placement, raising gross proceeds of C$771,776.92 through the issuance of 6,431,466 units at a price of C$0.12 per unit [1][4] - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of one share at C$0.25 for 24 months [2] - The net proceeds will primarily fund a preliminary economic assessment on the Balangero tailings retreatment project in Italy, exploration programs, and general working capital [4] Offering Details - The offering included finder's fees of C$2,805.60 and 23,380 compensation warrants, each allowing the acquisition of one unit at C$0.12 for 24 months [3] - The closing of the offering is subject to necessary regulatory approvals, including final approval from the TSX Venture Exchange [5] Related Party Transactions - Dr. Keith Barron, CEO and director, acquired 4,166,666 units in the offering, constituting a related party transaction [6] - Following the acquisition, Dr. Barron holds approximately 45.05% of the issued and outstanding common shares on a non-diluted basis [7][8] Company Overview - Aurania is focused on mineral exploration, particularly in precious metals and critical energy sectors in Europe and abroad [11]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors in Sprouts Farmers Market, Inc. for the period between June 4, 2025, and October 29, 2025, due to alleged misleading statements regarding the company's growth potential [2][6]. Group 1: Class Action Details - The class action is aimed at purchasers of Sprouts Farmers Market securities and sellers of put options during the specified Class Period [2][3]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A lead plaintiff must file a motion with the court by January 26, 2026, to represent other class members [4]. Group 2: Allegations Against the Company - The lawsuit claims that the defendants provided overly positive statements about Sprouts Farmers Market's growth potential while concealing material adverse facts [6]. - It is alleged that the company misled investors by asserting that a cautious consumer base would benefit the company, despite evidence suggesting a potential slowdown in sales growth [6]. - The lawsuit contends that when the true state of the company's growth potential was revealed, investors suffered damages [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [5]. - The firm has been recognized as a leader in the field, being ranked No. 1 for securities class action settlements in 2017 and consistently in the top 4 since 2013 [5]. - The founding partner has received accolades, including being named a Titan of Plaintiffs' Bar by Law360 in 2020 [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Skye Bioscience, Inc. to secure legal counsel before the January 16, 2026 deadline for a class action lawsuit related to securities purchased between November 4, 2024, and October 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Skye securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 16, 2026 [3] - The lawsuit alleges that defendants made materially false and misleading statements regarding Skye's business and the effectiveness of its product, nimacimab, which led to investor damages when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]

Core Viewpoint - Rosen Law Firm is encouraging investors of Primo Brands Corporation and Primo Water Corporation to secure legal counsel before the January 12, 2026 deadline for a securities class action lawsuit related to misrepresentations during the merger period [2][3][6]. Group 1: Class Action Details - The class action pertains to investors who purchased common stock of Primo Water Corporation between June 17, 2024, and November 8, 2024, and those who purchased common stock of Primo Brands Corporation between November 11, 2024, and November 6, 2025 [2][6]. - The lawsuit claims that the defendants misrepresented key facts about the merger between Primo Water and BlueTriton Brands, leading investors to believe in accelerated growth and strong financial results [6]. Group 2: Legal Representation - Investors are reminded that they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering hundreds of millions for investors [5]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the firm directly for more information [4][7]. - A lead plaintiff must be appointed by January 12, 2026, to represent the class in the litigation [4].

Core Viewpoint - Rosen Law Firm is urging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025 [2]. - Investors who purchased Perrigo securities during this period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must act by the January 16, 2026 deadline to serve as lead plaintiff [4]. Group 2: Reasons for Legal Counsel - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including underinvestment in maintenance and the need for substantial capital expenditures [6]. - It is claimed that these misrepresentations led to overstated financial results, affecting earnings and cash flow, and that the true state of the business caused investor damages when revealed [6].

Core Viewpoint - Predictmedix AI Inc. has successfully closed the final tranche of its non-brokered private placement, raising a total of $612,650 across all tranches, indicating strong investor interest and strategic alignment with long-term goals [2][3][5]. Group 1: Financial Details - In the final tranche, the company issued 3,050,000 units at a price of $0.05 per unit, resulting in gross proceeds of $152,500 [3][4]. - The total capital raised from all tranches of the offering amounts to $612,650 [3]. Group 2: Warrant Information - Each unit consists of one common share and one half of a common share purchase warrant, with each warrant allowing the purchase of one half common share at a price of C$0.15 for 36 months [4]. - If the volume weighted average price of the common shares reaches or exceeds $0.30 for 10 consecutive trading days, the company may accelerate the expiry date of the warrants [4]. Group 3: Strategic Approach - The company emphasized a disciplined, value-focused approach to the financing, prioritizing strategic contributions from investors over merely maximizing capital [5]. - The completion of this financing is expected to provide clarity and momentum for advancing initiatives in key markets [5]. Group 4: Company Overview - Predictmedix AI Inc. is an emerging provider of rapid health screening and remote patient care solutions, utilizing AI technology to analyze physiological data and predict health issues [6]. - The company's Smarthealth AI stations can assess 19 physiological vital parameters and detect impairments due to drugs, alcohol, fatigue, or mental illnesses [6].

Core Viewpoint - Restart Life Sciences Corp. has successfully closed the first tranche of its non-brokered private placement, raising a total of CDN$500,000 [1]. Group 1: Private Placement Details - The company issued 5,000,000 units at a price of CDN$0.10 per unit, with each unit consisting of one common share and one transferable common share purchase warrant [2]. - The warrants allow holders to purchase one additional common share for one year at a price of CAD $0.10 per share [2]. Group 2: Finder's Fees and Warrants - In connection with the placement, the company paid cash finder's fees totaling CAD $16,800 and issued 60,000 non-transferable finder warrants [3]. - Each finder warrant entitles the holder to purchase one common share for one year at a price of CAD $0.10 per share [3]. Group 3: Use of Proceeds - The proceeds from the offering will be used for health food trials, potential acquisitions, and general working capital [4]. - All securities issued under the placement are subject to a hold period of four months and one day, expiring on April 6, 2026 [4]. Group 4: Company Overview - Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the Canadian Securities Exchange [5].

Core Points - Diamond Estates Wines & Spirits Inc. issued 679,928 common shares at a deemed price of $0.21 per share as part of the acquisition of Perigon Beverage Group, marking the second tranche of share issuances based on gross margin earnouts [1] - The company also issued 254,885 common shares to 2RL Capital at a deemed price of $0.196 per share for ongoing services related to the Perigon acquisition [2] - A shareholder meeting is scheduled for December 22, 2025, with a strong encouragement for disinterested shareholders to vote in advance [3] Company Overview - Diamond Estates Wines & Spirits Inc. is a producer of high-quality wines and ciders and serves as a sales agent for over 120 beverage alcohol brands across Canada, operating four production facilities [4] - The company’s wine portfolio includes renowned brands from various countries, such as Fat Bastard from France and Kaiken from Argentina [6] - The spirits portfolio features distinguished brands like Tag Vodka and Ginslinger Gin from Ontario, as well as international brands from Mexico, Scotland, and the USA [7] - In the beer, cider, and ready-to-drink categories, the company represents products from Ontario, Belgium, the Netherlands, and Germany [8]

G. Scott Paterson Acquires Additional FUTR Shares Triggering Early Warning RequirementsDecember 05, 2025 4:57 PM EST | Source: G. Scott PatersonToronto, Ontario--(Newsfile Corp. - December 5, 2025) - Mr. G. Scott Paterson ("Mr. Paterson") today announced that he acquired 197,500 common shares of The FUTR Corporation (TSXV: FTRC) (OTCQB: FTRCF) (FSE: QA20) (WKN: A4165Y) (ISIN: CA3609521057) ("FUTR" or the "Company") at an average price of $0.30 per common share.On September 12, 2025, Mr. Paters ...